Best Life: Glynac -- a pill to cure the effects of aging?
ORLANDO, Fla. (Ivanhoe Newswire) -- According to research from Duke, your strength, balance and endurance start to decline in your 50′s. Cognitive decline can start as early as 45. Even though these are normal signs of aging, is there a way you can prevent these side effects from happening? One researcher believes a missing supplement may be the key to healthy aging.
Exercise … eating healthy … even lotions and potions. There are several things people do to stay young. But as much as we try, the clock keeps ticking away.
“The way you could walk and run when you were 20 years old is not what you’re doing when you’re 75 years old,” said Rajagopal Sekhar, MD, Associate Professor at Baylor College of Medicine.
That’s because as we get older, our bodies start to experience mitochondrial dysfunction.
“Mitochondria are tiny engines that supply the cell with energy. Mitochondrial dysfunction is linked to heart disease, to Alzheimer’s disease, to cognitive impairments, to almost every condition possible,” continued Dr. Sekhar.
Dr. Sekhar studies normal aging and says supplying the mitochondria with fuel may be the key to reversing some of the negative side effects of aging. That fuel is glynac, or a combination of glycine and n-acetylcysteine, components of a natural antioxidant glutathione. When older adults took the supplement for 12 weeks, muscle strength, gait speed, exercise capacity, and cognitive function all improved.
“And at 24 weeks, they were even better,” stated Dr. Sekhar.
After the participants in the trial stopped taking glynac, their improvements diminished. Dr. Sekhar is conducting two additional studies to test whether glynac could improve defects linked to cognitive decline in Alzheimer’s disease and in MCI.
Contributors to this news report include: Milvionne Chery, Producer; and Roque Correa, Editor.
Copyright 2022 WMC. All rights reserved.
Click here to sign up for our newsletter!
Click here to report a spelling or grammar error. Please include the headline.